Techno Medica Co., Ltd. (TYO:6678)
2,568.00
-18.00 (-0.70%)
At close: Feb 13, 2026
Techno Medica Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 8,745 | 9,061 | 8,586 | 11,750 | 11,523 | 10,138 |
Cash & Short-Term Investments | 8,745 | 9,061 | 8,586 | 11,750 | 11,523 | 10,138 |
Cash Growth | -2.28% | 5.53% | -26.93% | 1.97% | 13.66% | 3.85% |
Accounts Receivable | 2,658 | 3,904 | 4,297 | 3,574 | 3,652 | 3,605 |
Other Receivables | 679.05 | 48 | - | 83 | - | - |
Receivables | 3,337 | 3,952 | 4,297 | 3,657 | 3,652 | 3,605 |
Inventory | 2,640 | 2,607 | 2,154 | 1,865 | 1,229 | 1,646 |
Prepaid Expenses | 43.46 | 49 | 36 | 28 | 36 | 44 |
Other Current Assets | 6.65 | 9 | 8 | 7 | 32 | 37 |
Total Current Assets | 14,772 | 15,678 | 15,081 | 17,307 | 16,472 | 15,470 |
Property, Plant & Equipment | 1,363 | 1,404 | 1,448 | 1,527 | 1,492 | 1,564 |
Long-Term Investments | 7.51 | 331 | 410 | 210 | 146 | 171 |
Other Intangible Assets | 51.92 | 59 | 71 | 22 | 33 | 23 |
Long-Term Deferred Tax Assets | 433.66 | 465 | 422 | 375 | 363 | 324 |
Other Long-Term Assets | 324.95 | 1 | 1 | 2 | 2 | 2 |
Total Assets | 16,954 | 17,938 | 17,433 | 19,443 | 18,508 | 17,554 |
Accounts Payable | 840.61 | 1,576 | 1,416 | 1,499 | 1,282 | 1,134 |
Accrued Expenses | 259.97 | 305 | 294 | 273 | 259 | 251 |
Current Income Taxes Payable | 15.42 | 378 | 778 | 413 | 665 | 636 |
Current Unearned Revenue | 112.83 | 107 | 96 | 98 | 114 | 134 |
Other Current Liabilities | 796.46 | 909 | 775 | 527 | 310 | 229 |
Total Current Liabilities | 2,025 | 3,275 | 3,359 | 2,810 | 2,630 | 2,384 |
Pension & Post-Retirement Benefits | 243.23 | 239 | 220 | 210 | 192 | 174 |
Other Long-Term Liabilities | 210.15 | 35 | 36 | 37 | 36 | 36 |
Total Liabilities | 2,479 | 3,549 | 3,615 | 3,057 | 2,858 | 2,594 |
Common Stock | 1,070 | 1,069 | 1,069 | 1,069 | 1,069 | 1,069 |
Additional Paid-In Capital | 985.76 | 996 | 1,002 | 967 | 967 | 967 |
Retained Earnings | 16,255 | 16,265 | 15,730 | 14,890 | 14,260 | 13,416 |
Treasury Stock | -3,835 | -3,941 | -3,984 | -541 | -648 | -493 |
Comprehensive Income & Other | 0 | - | 1 | 1 | 2 | 1 |
Shareholders' Equity | 14,475 | 14,389 | 13,818 | 16,386 | 15,650 | 14,960 |
Total Liabilities & Equity | 16,954 | 17,938 | 17,433 | 19,443 | 18,508 | 17,554 |
Net Cash (Debt) | 8,745 | 9,061 | 8,586 | 11,750 | 11,523 | 10,138 |
Net Cash Growth | -2.28% | 5.53% | -26.93% | 1.97% | 13.66% | 3.85% |
Net Cash Per Share | 1255.14 | 1308.54 | 1101.49 | 1392.21 | 1356.54 | 1193.61 |
Filing Date Shares Outstanding | 6.97 | 6.93 | 6.95 | 8.47 | 8.43 | 8.52 |
Total Common Shares Outstanding | 6.97 | 6.93 | 6.95 | 8.47 | 8.43 | 8.52 |
Working Capital | 12,747 | 12,403 | 11,722 | 14,497 | 13,842 | 13,086 |
Book Value Per Share | 2077.51 | 2076.70 | 1987.84 | 1933.92 | 1855.48 | 1755.94 |
Tangible Book Value | 14,423 | 14,330 | 13,747 | 16,364 | 15,617 | 14,937 |
Tangible Book Value Per Share | 2070.06 | 2068.19 | 1977.62 | 1931.33 | 1851.57 | 1753.24 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.